APEX1 and lung adenocarcinoma: Analysis of the GEPIA2 database showed that versus the normal samples, the expression of APE1 was increased in both lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) samples (Figure 3F).